Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification of Biomarkers and Critical Evaluation of Biomarker Validation in Hidradenitis Suppurativa
Samuel A Der Sarkissian, Schapoor Hessam, Joslyn S. Kirby, et al.
JAMA Dermatology (2022) Vol. 158, Iss. 3, pp. 300-300
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Unravelling the complex pathogenesis of hidradenitis suppurativa
John W. Frew
British Journal of Dermatology (2025) Vol. 192, Iss. Supplement_1, pp. i3-i14
Open Access | Times Cited: 2
New and Emerging Targeted Therapies for Hidradenitis Suppurativa
Adela Markota Čagalj, Branka Marinović, Zrinka Bukvić Mokoš
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3753-3753
Open Access | Times Cited: 54
Hidradenitis suppurativa: new insights into disease mechanisms and an evolving treatment landscape
James G. Krueger, John W. Frew, Gregor B. E. Jemec, et al.
British Journal of Dermatology (2023) Vol. 190, Iss. 2, pp. 149-162
Open Access | Times Cited: 28
Biologics for Hidradenitis suppurativa: evolution of the treatment paradigm
Carlo Alberto Maronese, Chiara Moltrasio, Giovanni Genovese, et al.
Expert Review of Clinical Immunology (2023) Vol. 20, Iss. 5, pp. 525-545
Closed Access | Times Cited: 26
Brepocitinib, Zimlovisertib, and Ropsacitinib in Hidradenitis Suppurativa
Alexa B. Kimball, Elena Peeva, Seth Forman, et al.
NEJM Evidence (2024) Vol. 3, Iss. 3
Closed Access | Times Cited: 13
The Genomic Architecture of Hidradenitis Suppurativa—A Systematic Review
Nikolai Paul Pace, Dillon Mintoff, Isabella Borg
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 28
A proof-of-concept open-label clinical trial of spleen tyrosine kinase antagonism using fostamatinib in moderate-to-severe hidradenitis suppurativa
Rebecca Jepsen, C M Edwards, Akshay Flora, et al.
Journal of the American Academy of Dermatology (2023) Vol. 89, Iss. 4, pp. 694-702
Closed Access | Times Cited: 19
The use of ultrasound and magnetic resonance imaging in the management of hidradenitis suppurativa: a narrative review
Pedro Mendes‐Bastos, A. Martorell, Vincenzo Bettoli, et al.
British Journal of Dermatology (2023) Vol. 188, Iss. 5, pp. 591-600
Open Access | Times Cited: 18
The Essential Role of microRNAs in Inflammatory and Autoimmune Skin Diseases—A Review
Klaudia Dopytalska, Anna Czaplicka, Elżbieta Szymańska, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9130-9130
Open Access | Times Cited: 17
Precision Dermatology: A Review of Molecular Biomarkers and Personalized Therapies
Isabella J. Tan, Alicia Podwójniak, Aarushi K. Parikh, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 4, pp. 2975-2990
Open Access | Times Cited: 7
Obesity and hidradenitis suppurativa: targeting meta-inflammation for therapeutic gain
Dillon Mintoff, Rachel Agius, Farida Benhadou, et al.
Clinical and Experimental Dermatology (2023) Vol. 48, Iss. 9, pp. 984-990
Closed Access | Times Cited: 15
Deregulated Long Non-Coding RNAs (lncRNA) as Promising Biomarkers in Hidradenitis Suppurativa
Uppala Radhakrishna, Uppala Ratnamala, Devendrasinh Jhala, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 10, pp. 3016-3016
Open Access | Times Cited: 5
Bridging the gap in early diagnosis of hidradenitis suppurativa
Natalia Chalupczak, Katie Lovell, Steven R. Feldman
Archives of Dermatological Research (2025) Vol. 317, Iss. 1
Closed Access
Serum Immunoglobulin G Levels and Nicastrin Variation in Hidradenitis Suppurativa
Dillon Mintoff, Nikolai Paul Pace
JAMA Dermatology (2025)
Closed Access
Hidradenitis suppurativa, from basic science to surgery and a new era of tailored targeted therapy: An expert opinion paper
Angelo Valerio Marzano, Michele Bartoletti, Vincenzo Bettoli, et al.
Archives of Dermatological Research (2025) Vol. 317, Iss. 1
Open Access
Hidradenitis Suppurativa Biomarkers
Raj H. Patel, Jessica N. Pixley, Luna Samman, et al.
(2025), pp. 213-228
Closed Access
Skin and Gut Microbiome in Hidradenitis Suppurativa: A Systematic Review
Edyta Lelonek, Dorra Bouazzi, Gregor B. E. Jemec, et al.
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2277-2277
Open Access | Times Cited: 12
Biomarkers in rosacea: A systematic review
Ryan S.Q. Geng, Adrienn N. Bourkas, R. Gary Sibbald, et al.
Journal of the European Academy of Dermatology and Venereology (2023) Vol. 38, Iss. 6, pp. 1048-1057
Open Access | Times Cited: 12
Haptoglobin is an independent marker for disease severity and risk for metabolic complications in hidradenitis suppurativa: A prospective study
Nessr Abu Rached, Thilo Gambichler, Lennart Ocker, et al.
Journal of the European Academy of Dermatology and Venereology (2023) Vol. 38, Iss. 1, pp. 205-213
Open Access | Times Cited: 11
Causal association between body fat percentage and hidradenitis suppurativa: A two‐sample Mendelian randomization study
Dillon Mintoff, Nikolai Paul Pace
Journal of the European Academy of Dermatology and Venereology (2025)
Closed Access
Neutrophil Extracellular Traps Are Widely Distributed Across Lesional and Perilesional Hidradenitis Suppurativa Skin, and Elevated Serum NET Markers Associate With Moderate to Severe HS Disease
S. van Dalen, Judy Stein, Tirza Bruurmijn, et al.
International Journal of Dermatology (2025)
Open Access
Effects of QazVac Vaccination on Immune and Clinical Characteristics in Patients With and Without Long COVID-19
Saulesh S. Kurmangaliyeva, Akzhan M. Madenbayeva, Saltanat T. Urazayeva, et al.
West Kazakhstan Medical Journal (2025) Vol. 67, Iss. 1, pp. 24-41
Open Access
Disease Association of Anti‒Carboxyethyl Lysine Autoantibodies in Hidradenitis Suppurativa
Giulio Macchiarella, Vanessa Cornacchione, Celine Cojean, et al.
Journal of Investigative Dermatology (2022) Vol. 143, Iss. 2, pp. 273-283.e12
Open Access | Times Cited: 17
Modulation of Disease-Associated Pathways in Hidradenitis Suppurativa by the Janus Kinase 1 Inhibitor Povorcitinib: Transcriptomic and Proteomic Analyses of Two Phase 2 Studies
Huiqing Liu, Leandro L. Santos, Susan H. Smith
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7185-7185
Open Access | Times Cited: 9
Aberrant expression of interleukin-17A in mast cells contributes to the pathogenesis of hidradenitis suppurativa
Chia‐Bao Chu, Chao‐Chun Yang, Yuan‐Yu Hsueh, et al.
British Journal of Dermatology (2023) Vol. 189, Iss. 6, pp. 719-729
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top